Theo S Plantinga

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 5

Top Topics

Dna Methylation

Systematic Review

Multiple Myeloma

Top Venues

Nature communications

Molecular cancer therapeutics

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jantine E Bakema, Marijke Stigter van Walsum, Jeffrey R Harris, Sonja H Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S Plantinga, Elisabeth Bloemena, Ruud H Brakenhoff, Esther C W Breij, Rieneke van de Ven
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy. Molecular cancer therapeutics (2023)
Alexander Muik, Elena Garralda, Isil Altintas, Friederike Gieseke, Ravit Geva, Eytan Ben-Ami, Corinne Maurice-Dror, Emiliano Calvo, Patricia M LoRusso, Guzman Alonso, Maria E Rodriguez-Ruiz, Kristina B Schoedel, Jordan M Blum, Bianca Sänger, Theodora W Salcedo, Saskia M Burm, Eliana Stanganello, Dennis Verzijl, Fulvia Vascotto, Angelica Sette, Juliane Quinkhardt, Theo S Plantinga, Aras Toker, Edward N van den Brink, Mark Fereshteh, Mustafa Diken, David Satijn, Sebastian Kreiter, Esther C W Breij, Gaurav Bajaj, Eleni Lagkadinou, Kate Sasser, Özlem Türeci, Ulf Forssmann, Tahamtan Ahmadi, Uğur Şahin, Maria Jure-Kunkel, Ignacio Melero Bermejo
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors. Cancer discovery 12 (5) (2022)
Wei Zhou, Ben Michael Brumpton, Omer Kabil, Julius Gudmundsson, Gudmar Thorleifsson, Joshua S Weinstock, Matthew Zawistowski, Jonas Bille Nielsen, Layal Chaker, Marco Medici, Alexander Teumer, Silvia Naitza, Serena Sanna, Ulla T Schultheiss, Anne Cappola, Juha Karjalainen, Mitja Kurki, Morgan Oneka, Peter Taylor, Lars G Fritsche, Sarah E Graham, Brooke N Wolford, William Overton, Humaira Rasheed, Eirin B Haug, Maiken E Gabrielsen, Anne Heidi Skogholt, Ida Surakka, George Davey Smith, Anita Pandit, Tanmoy Roychowdhury, Whitney E Hornsby, Jon G Jonasson, Leigha Senter, Sandya Liyanarachchi, Matthew D Ringel, Li Xu, Lambertus A L M Kiemeney, Huiling He, Romana T Netea-Maier, Jose I Mayordomo, Theo S Plantinga, Jon Hrafnkelsson, Hannes Hjartarson, Erich M Sturgis, Aarno Palotie, Mark Daly, Cintia E Citterio, Peter Arvan, Chad M Brummett, Michael Boehnke, Albert de la Chapelle, Kári Stefánsson, Kristian Hveem, Cristen J Willer, Bjørn Olav Åsvold
Author Correction: GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer. Nature communications 12 (1) (2021)
Wei Zhou, Ben Michael Brumpton, Omer Kabil, Julius Gudmundsson, Gudmar Thorleifsson, Joshua S Weinstock, Matthew Zawistowski, Jonas Bille Nielsen, Layal Chaker, Marco Medici, Alexander Teumer, Silvia Naitza, Serena Sanna, Ulla T Schultheiss, Anne Cappola, Juha Karjalainen, Mitja Kurki, Morgan Oneka, Peter Taylor, Lars G Fritsche, Sarah E Graham, Brooke N Wolford, William Overton, Humaira Rasheed, Eirin B Haug, Maiken E Gabrielsen, Anne Heidi Skogholt, Ida Surakka, George Davey Smith, Anita Pandit, Tanmoy Roychowdhury, Whitney E Hornsby, Jon G Jonasson, Leigha Senter, Sandya Liyanarachchi, Matthew D Ringel, Li Xu, Lambertus A L M Kiemeney, Huiling He, Romana T Netea-Maier, Jose I Mayordomo, Theo S Plantinga, Jon Hrafnkelsson, Hannes Hjartarson, Erich M Sturgis, Aarno Palotie, Mark Daly, Cintia E Citterio, Peter Arvan, Chad M Brummett, Michael Boehnke, Albert de la Chapelle, Kári Stefánsson, Kristian Hveem, Cristen J Willer, Bjørn Olav Åsvold
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. Nature communications 11 (1) (2020)
Rob J W Arts, Theo S Plantinga, Sander Tuit, Thomas Ulas, Bas Heinhuis, Marika Tesselaar, Yvette Sloot, Gosse J Adema, Leo A B Joosten, Johannes W A Smit, Mihai M Netea, Joachim L Schultze, Romana T Netea-Maier
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages. Oncoimmunology 5 (12) (2016)